Agrylin Capsule
NDC 54092-063
Product Information
Agrylin (anagrelide hydrochloride) is a NDA-approved product labeled by Takeda Pharmaceuticals America, Inc.. Anagrelide is used to treat a certain blood disorder (thrombocythemia), which is caused by your bone marrow making too many platelets. It is supplied as a white capsule for oral administration. This product entry covers the primary NDC 54092-063 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
S063
Code Structure Chart
Product Details
What is NDC 54092-063?
What are the uses of this product?
What are Active Ingredients of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- ANAGRELIDE HYDROCHLORIDE (UNII: VNS4435G39)
- ANAGRELIDE (UNII: K9X45X0051) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- ANHYDROUS LACTOSE (UNII: 3SY5LH9PMK)
- CROSPOVIDONE, UNSPECIFIED (UNII: 2S7830E561)
- LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)
- POVIDONE K30 (UNII: U725QWY32X)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 597850 - anagrelide HCl 0.5 MG Oral Capsule
- RxCUI: 597850 - anagrelide 0.5 MG Oral Capsule
- RxCUI: 597850 - anagrelide 0.5 MG (as anagrelide HCl) Oral Capsule
- RxCUI: 597857 - Agrylin 0.5 MG Oral Capsule
- RxCUI: 597857 - anagrelide 0.5 MG Oral Capsule [Agrylin]
Which are the Pharmacologic Classes of this product?
* Please review the full disclaimer at the bottom of this page.
Patient Education
Anagrelide
Anagrelide is used to decrease the number of platelets (a type of blood cell that is needed to control bleeding) in the blood of patients who have a bone marrow disorder, in which the body makes too many of one or more types of blood cells, such as essential thrombocythemia (condition in which the body makes too many platelets) or polycythemia vera (condition in which the body makes too many red blood cells and sometimes too many platelets). Anagrelide is in a class of medications called platelet-reducing agents. It works by slowing the production of platelets in the body.
[Learn More]
* Please review the full disclaimer at the bottom of this page.